Qishe Pill for Cervical Radiculopathy
Primary Purpose
Cervical Radiculopathy
Status
Unknown status
Phase
Phase 2
Locations
China
Study Type
Interventional
Intervention
Qishe Pill
Qishe Placebo
Sponsored by
About this trial
This is an interventional treatment trial for Cervical Radiculopathy
Eligibility Criteria
Inclusion Criteria:
- clinical diagnosis of chronic neck pain since at least 3 months and complaints for a maximum duration of 5 years.
- average pain intensity of the last 7 days more or equal to 25 points measured by a Neck Disability Index.
- intellectual and physical ability to participate in the study.
- informed consent.
- One positive result of Brachial Plexus Traction Test, Cervical compression test or Cervical distraction test
Exclusion Criteria:
- cervical pain related to malignancy
- cervical pain due to an accident
- inflammatory joint disorders
- previous spine surgery
- protrusion/prolapse of a spinal disk, spondylolisthesis, with radicular symptomatology
- actually doing or planning to do other regular physical exercise during the study with possible positive effects on neck pain - such as swimming, yoga, pilates, tai chi, etc.
- use of pain drugs for other diseases (> 1x/week)
- pregnancy
- severe chronic or acute disease interfering with therapy attendance
- alcohol or substance abuse
- participation in another clinical trial in the last 6 months before study entry
Sites / Locations
- No.1 Hospital, Changchun University of TCM
- Gansu Hospital of TCM
- Huadong Hospital
- Longhua Hospital
- Suzhou Hospital of TCMRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
Qishe
Control
Arm Description
Qishe Placebo
Outcomes
Primary Outcome Measures
pain severity(measured with a visual analogue scale, VAS)
Operationally, the VAS score display as a horizontal line, 100 mm in length, word descriptors anchored at each end. The patient marks on the line the point that they feel represents their perception of their current pain. The VAS score is then determined by measuring in millimetres from the left hand end of the line to the point that the patient marks.
pain severity(measured with a visual analogue scale, VAS)
Operationally, the VAS score display as a horizontal line, 100 mm in length, word descriptors anchored at each end. The patient marks on the line the point that they feel represents their perception of their current pain. The VAS score is then determined by measuring in millimetres from the left hand end of the line to the point that the patient marks.
Secondary Outcome Measures
SF-36
a composite of functional status
Neck Disability Index(NDI)
a composite of functional status
Patient satisfaction degree
To evaluate satisfaction
SF-36
a composite of functional status
Neck Disability Index(NDI)
a composite of functional status
Neck Disability Index(NDI)
a composite of functional status
Neck Disability Index(NDI)
a composite of functional status
Safety evaluation
Safety evaluation
The medicine issue
Compliance assessment
To evaluate compliance
Compliance assessment
To evaluate compliance
Concomitant medication
Concomitant medication
X-ray(frontal and lateral)
Kidney function test
Liver function test
ECG
Occult Blood
Excrement routine
Urine routine
Blood routine
Full Information
NCT ID
NCT01274936
First Posted
December 14, 2010
Last Updated
November 11, 2014
Sponsor
Shanghai University of Traditional Chinese Medicine
Collaborators
Fudan University, Changchun University of Chinese Medicine, Lanzhou Hospital of Traditional Chinese Medicine, Suzhou Hospital of Traditional Chinese Medicine
1. Study Identification
Unique Protocol Identification Number
NCT01274936
Brief Title
Qishe Pill for Cervical Radiculopathy
Official Title
Effectiveness of a Compound Traditional Chinese Herbal Medicine, Qishe Pill, on Cervical Radiculopathy: a Randomized, Double-blind, Placebo-controlled, Multicentre Trial
Study Type
Interventional
2. Study Status
Record Verification Date
November 2014
Overall Recruitment Status
Unknown status
Study Start Date
March 2012 (undefined)
Primary Completion Date
February 2015 (Anticipated)
Study Completion Date
June 2015 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Shanghai University of Traditional Chinese Medicine
Collaborators
Fudan University, Changchun University of Chinese Medicine, Lanzhou Hospital of Traditional Chinese Medicine, Suzhou Hospital of Traditional Chinese Medicine
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Radiculopathy generally presents with pain, numbness, or weakness in a dermatomal distribution. Cervical radiculopathy results from impingement on a nerve root by either spondylotic narrowing of the neural foramen or a lateral intervertebral disc herniation. Specifically, it should be the goal of the treating physician to relieve pain, improve function, and prevent recurrence. Various studies have shown that nonoperative management of cervical radiculopathy leaves a substantial minority of patients with persistently troublesome symptoms. Pharmacologic agents treat the underlying condition and provide symptomatic relief. The various classes of medications used to treat radiculopathy include steroids, nonsteroidal antiinflammatory drugs (NSAIDs), muscle relaxants, narcotics, and antidepressants. Herbal medicines have been used for centuries in China. In China, many patients with cervical disc disease are increasingly turning to herbal medicines to alleviate their symptoms and reduce the side effects of medications. The goal of this study is to determine the efficacy and efficacy of an herbal medicine, Qishe Pill, to treat cervical radiculopathy.
Detailed Description
Cervical radiculopathy is a distinct consideration in the evaluation of any patients who have neck pain and may be defined simply as an abnormality of a nerve root, which originates in the cervical spine. The initial approach to the management of cervical spondylopathy radiculopathy is nearly the same that the nonspecific neck or back pain can be found in most of patients. Conservative treatments include non-steroidal anti-inflammatory drugs (NSAIDs), narcotics, muscle relaxants, physical therapy and transcutaneous electrical nerve stimulation (TENS). The main objectives of conservative treatments are to relieve pain, improve function and improve health-related quality of life.However, these treatments for cervical radiculopathy are limited by their modest effectiveness. Surgical treatment for cervical disc disease is indicated when symptoms are refractory to conservative treatments and neurological symptoms are progressive. In terms of pharmacotherapy, there generally is no randomized, placebo-controlled trial available comparing the standard nonsurgical treatments. Therefore, care plans should be designed principally based on accumulated experience, the services available locally, and the respective preferences of patients. Treatment plans are developed to alleviate pain, improve function, and prevent recurrences.
As a complementary and alternative medicine (CAM), herbal medicines have the potential to avoid the adverse effects of medications and surgery.In the basic theory of traditional Chinese medicine (TCM), the obstruction of Qi flow and blood circulation in the neck area caused by some pathogenic factors, such as "Feng"(wind), "Han"(cold), "Shi"(dampness), invading the neck, induces cervical degenerative disc diseases which are the cause of cervical radiculopathy. According to the four traditional methods of diagnosis - observation, listening, interrogation, and pulse-taking, on patients, TCM doctors can analyze the certain pathogenic factors which cause neck pain. And then they will prescribe herbal formulae based on the effect and the main indications of Chinese medicine. Natural substances, including herbal medicines, have being used to promote healing and alleviate neck pain in western countries. Previous studies have demonstrated that some active substances in herbal medicine can promote Qi flow and blood circulation to alleviate pain.
A number of studies on the effects of the Chinese herbal medicine on cervical radiculopathy have been proposed, but useful empirical research is insufficiency. For chronic neck pain with or without radicular symptoms, there is low quality evidence that herbal is more effective than placebo for pain relief, which is measured at the end of the treatment. However, the size of the studies was small and the effect was measured in the short-term. Further research is very likely to change both the effect size and our confidence in the results. There is a need for trials with adequate numbers of participants that address long-term efficacy or effectiveness of herbal medicine compared to placebo.
Qishe Pill is composed of processed Radix Astragali, Muscone, Szechuan Lovage Rhizome, Radix Stephaniae Tetrandrae, Ovientvine, Calculus Bovis Artifactus. Using a well-designed clinical trial, we will survey the effectiveness of concurrent use of this remedy in relieving neck pain. Therefore, the present study is to examine effectiveness and safety of Qishe Pill, a compound traditional Chinese herbal medicine, on neck pain in cervical spondylotic radiculopathy in a randomized, double-blind, placebo-controlled trial. Results of this study will provide evidence regarding the value of the Qishe Pill as an intervention to alleviate neck pain caused by cervical radiculopathy.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cervical Radiculopathy
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
240 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Qishe
Arm Type
Experimental
Arm Title
Control
Arm Type
Placebo Comparator
Arm Description
Qishe Placebo
Intervention Type
Drug
Intervention Name(s)
Qishe Pill
Intervention Description
Pill, 3.75 g, twice per day, four weeks
Intervention Type
Drug
Intervention Name(s)
Qishe Placebo
Intervention Description
Pill, 3.75 g, twice per day, four weeks
Primary Outcome Measure Information:
Title
pain severity(measured with a visual analogue scale, VAS)
Description
Operationally, the VAS score display as a horizontal line, 100 mm in length, word descriptors anchored at each end. The patient marks on the line the point that they feel represents their perception of their current pain. The VAS score is then determined by measuring in millimetres from the left hand end of the line to the point that the patient marks.
Time Frame
changes from baseline at 2 weeks
Title
pain severity(measured with a visual analogue scale, VAS)
Description
Operationally, the VAS score display as a horizontal line, 100 mm in length, word descriptors anchored at each end. The patient marks on the line the point that they feel represents their perception of their current pain. The VAS score is then determined by measuring in millimetres from the left hand end of the line to the point that the patient marks.
Time Frame
changes from baseline at 4 weeks
Secondary Outcome Measure Information:
Title
SF-36
Description
a composite of functional status
Time Frame
changes from baseline at 2 weeks
Title
Neck Disability Index(NDI)
Description
a composite of functional status
Time Frame
changes from baseline at 2 weeks
Title
Patient satisfaction degree
Description
To evaluate satisfaction
Time Frame
Changes from baseline at 4 weeks
Title
SF-36
Description
a composite of functional status
Time Frame
changes from baseline at 4 weeks
Title
Neck Disability Index(NDI)
Description
a composite of functional status
Time Frame
changes from baseline at 4 weeks
Title
Neck Disability Index(NDI)
Description
a composite of functional status
Time Frame
changes from baseline at 3 months
Title
Neck Disability Index(NDI)
Description
a composite of functional status
Time Frame
changes from baseline at 6 months
Title
Safety evaluation
Description
Safety evaluation
Time Frame
changes from baseline at 4 weeks
Title
The medicine issue
Time Frame
changes from baseline at 2 weeks
Title
Compliance assessment
Description
To evaluate compliance
Time Frame
changes from baseline at 2 weeks
Title
Compliance assessment
Description
To evaluate compliance
Time Frame
changes from baseline at 4 weeks
Title
Concomitant medication
Time Frame
changes from baseline at 2 weeks
Title
Concomitant medication
Time Frame
changes from baseline at 4 weeks
Title
X-ray(frontal and lateral)
Time Frame
changes from baseline at 4 weeks
Title
Kidney function test
Time Frame
changes from baseline at 4 weeks
Title
Liver function test
Time Frame
changes from baseline at 4 weeks
Title
ECG
Time Frame
changes from baseline at 4 weeks
Title
Occult Blood
Time Frame
changes from baseline at 4 weeks
Title
Excrement routine
Time Frame
changes from baseline at 4 weeks
Title
Urine routine
Time Frame
changes from baseline at 4 weeks
Title
Blood routine
Time Frame
changes from baseline at 4 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
clinical diagnosis of chronic neck pain since at least 3 months and complaints for a maximum duration of 5 years.
average pain intensity of the last 7 days more or equal to 25 points measured by a Neck Disability Index.
intellectual and physical ability to participate in the study.
informed consent.
One positive result of Brachial Plexus Traction Test, Cervical compression test or Cervical distraction test
Exclusion Criteria:
cervical pain related to malignancy
cervical pain due to an accident
inflammatory joint disorders
previous spine surgery
protrusion/prolapse of a spinal disk, spondylolisthesis, with radicular symptomatology
actually doing or planning to do other regular physical exercise during the study with possible positive effects on neck pain - such as swimming, yoga, pilates, tai chi, etc.
use of pain drugs for other diseases (> 1x/week)
pregnancy
severe chronic or acute disease interfering with therapy attendance
alcohol or substance abuse
participation in another clinical trial in the last 6 months before study entry
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Xuejun Cui, Dr
Email
13917715524@139.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Yongjun Wang, Dr
Organizational Affiliation
Longhua Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
No.1 Hospital, Changchun University of TCM
City
Changchun
Country
China
Individual Site Status
Completed
Facility Name
Gansu Hospital of TCM
City
Lanzhou
Country
China
Individual Site Status
Completed
Facility Name
Huadong Hospital
City
Shanghai
ZIP/Postal Code
200032
Country
China
Individual Site Status
Completed
Facility Name
Longhua Hospital
City
Shanghai
ZIP/Postal Code
200032
Country
China
Individual Site Status
Completed
Facility Name
Suzhou Hospital of TCM
City
Suzhou
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Hong Jiang, PhD
First Name & Middle Initial & Last Name & Degree
Xiang Qin, Master
12. IPD Sharing Statement
Citations:
PubMed Identifier
24099350
Citation
Cui XJ, Sun YL, You SF, Mo W, Lu S, Shi Q, Wang YJ. Effects of Qishe Pill, a compound traditional Chinese herbal medicine, on cervical radiculopathy: study protocol for a randomized controlled trial. Trials. 2013 Oct 7;14:322. doi: 10.1186/1745-6215-14-322.
Results Reference
derived
Learn more about this trial
Qishe Pill for Cervical Radiculopathy
We'll reach out to this number within 24 hrs